Drug Database
Back to search

Netherlands· NL-85e8e4ccc7a2

Clemastine Macure 1 mg/ml oplossing voor injectie

A clemastine product containing clemastinewaterstoffumaraat, registered in Netherlands by Macure Healthcare Limited. The same ATC class is registered in 11 of our 19 countries.

ATC R06AA04

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedClemastine Macure 1 mg/ml oplossing v…ATCR06AA04REGISTER NO.NL-85e8e4ccc7a2PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about clemastinewaterstoffumaraatAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Clemastine is registered in 11 of 19 countries.

Countries holding a registration under ATC R06AA04 (clemastine), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 6 of them publish a price we can compare per daily dose
Search clemastine products by name

Clemastine · ATC R06AA04

11 / 19 countries

  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
CLEMASTINEWATERSTOFFUMARAAT
Manufacturer
Macure Healthcare Limited
Country
Netherlands (NL)
ATC code
R06AA04
ATC class
Clemastine
Defined daily dose
2 mg, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    134711

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

321 interactions on record for clemastine.

Graded by severity as the source publishes them — 9 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check clemastine against other medicinesHow interaction checks work

Clemastine · interactions on record

321 records

  • 9 severe
  • 309 moderate
  • 3 minor

Most severe, free to view

  • Potassium chlorideA12BA01severe
  • Potassium citrateA12BA02severe
  • Potassium chlorideB05XA01severe
  • Sodium oxybateN01AX11severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Clemastine in 10 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All clemastine products

Authorised across Europe · EMA

The same active substance is authorised in 12 EEA countries. Names it is sold under:

  • Germany · Tavegil, Tavegil Tabletten
  • Denmark · Clemastine Macure
  • Estonia · Tavegyl
  • Finland · Clemastine Macure
  • United Kingdom (Northern Ireland) · Tavegil
  • Iceland · Tavegyl
  • Lithuania · Clemastinum Pph, Tavegyl
  • Latvia · Tavegyl
  • Norway · Clemastine Macure
  • Poland · Clemastinum Aflofarm, Clemastinum Hasco
  • Portugal · Tavégyl, Tavist
  • Sweden · Clemastine Macure, Tavegyl

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/faa7c1bb-b4c7-4ce6-8f0d-243ef206aa30
GET /v1/drugs/faa7c1bb-b4c7-4ce6-8f0d-243ef206aa30?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oplossing voor injectie",
  "route": "Intraveneus gebruik, Intramusculair gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h134711_smpc.pdf",
  "strength": null,
  "atc_label": "Clemastine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg134711",
  "excipients": [
    "ETHANOL 96 %",
    "PROPYLEENGLYCOL (E 1520)",
    "SORBITOL, VLOEIBAAR, NIET-KRISTALLISEERBAAR (E 420)",
    "TRINATRIUMCITRAAT 2-WATER (E 331)",
    "WATER VOOR INJECTIE"
  ],
  "substances": [
    "CLEMASTINEWATERSTOFFUMARAAT"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h134711.pdf",
  "authorised_at": "2026/04/22",
  "procedure_number": "NL/H/6351/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "134711",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about clemastine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console